202 related articles for article (PubMed ID: 31087217)
1. Development and validation of Alzheimer's Disease Animal Model for the Purpose of Regenerative Medicine.
Goodarzi P; Payab M; Alavi-Moghadam S; Larijani B; Rahim F; Bana N; Sarvari M; Adibi H; Foroughi Heravani N; Hadavandkhani M; Arjmand B
Cell Tissue Bank; 2019 Jun; 20(2):141-151. PubMed ID: 31087217
[TBL] [Abstract][Full Text] [Related]
2. Animal models of Alzheimer's disease: therapeutic implications.
Woodruff-Pak DS
J Alzheimers Dis; 2008 Dec; 15(4):507-21. PubMed ID: 19096153
[TBL] [Abstract][Full Text] [Related]
3. Neural regeneration therapies for Alzheimer's and Parkinson's disease-related disorders.
Reddy AP; Ravichandran J; Carkaci-Salli N
Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165506. PubMed ID: 31276770
[TBL] [Abstract][Full Text] [Related]
4. Being human: The role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer's disease models.
Sproul AA
Mol Aspects Med; 2015; 43-44():54-65. PubMed ID: 26101165
[TBL] [Abstract][Full Text] [Related]
5. Stem Cells in Alzheimer's Disease: Current Standing and Future Challenges.
Salem H; Colpo GD; Teixeira AL
Adv Exp Med Biol; 2018; 1079():93-102. PubMed ID: 29767290
[TBL] [Abstract][Full Text] [Related]
6. Bridging the Gap between Alzheimer's Disease and Alzheimer's-like Diseases in Animals.
Gołaszewska A; Bik W; Motyl T; Orzechowski A
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987146
[TBL] [Abstract][Full Text] [Related]
7. Animal models of Alzheimer's disease: an understanding of pathology and therapeutic avenues.
Obulesu M; Rao DM
Int J Neurosci; 2010 Aug; 120(8):531-7. PubMed ID: 20615056
[TBL] [Abstract][Full Text] [Related]
8. Regenerative medicine in Alzheimer's disease.
Felsenstein KM; Candelario KM; Steindler DA; Borchelt DR
Transl Res; 2014 Apr; 163(4):432-8. PubMed ID: 24286919
[TBL] [Abstract][Full Text] [Related]
9. The Design and Application of an Appropriate Parkinson's Disease Animal Model in Regenerative Medicine.
Larijani B; Goodarzi P; Payab M; Tayanloo-Beik A; Sarvari M; Gholami M; Gilany K; Nasli-Esfahani E; Yarahmadi M; Ghaderi F; Arjmand B
Adv Exp Med Biol; 2021; 1341():89-105. PubMed ID: 31485993
[TBL] [Abstract][Full Text] [Related]
10. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model.
Cheng XR; Zhou WX; Zhang YX
Ageing Res Rev; 2014 Jan; 13():13-37. PubMed ID: 24269312
[TBL] [Abstract][Full Text] [Related]
11. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
[TBL] [Abstract][Full Text] [Related]
12. Overview and perspective on the therapy of Alzheimer's disease from a preclinical viewpoint.
Pepeu G
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Jan; 25(1):193-209. PubMed ID: 11263752
[TBL] [Abstract][Full Text] [Related]
13. Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease.
Opii WO; Joshi G; Head E; Milgram NW; Muggenburg BA; Klein JB; Pierce WM; Cotman CW; Butterfield DA
Neurobiol Aging; 2008 Jan; 29(1):51-70. PubMed ID: 17055614
[TBL] [Abstract][Full Text] [Related]
14. Regenerative therapy for hippocampal degenerative diseases: lessons from preclinical studies.
Venugopal C; Chandanala S; Prasad HC; Nayeem D; Bhonde RR; Dhanushkodi A
J Tissue Eng Regen Med; 2017 Feb; 11(2):321-333. PubMed ID: 26118731
[TBL] [Abstract][Full Text] [Related]
15. Gene Therapy Models of Alzheimer's Disease and Other Dementias.
Combs B; Kneynsberg A; Kanaan NM
Methods Mol Biol; 2016; 1382():339-66. PubMed ID: 26611599
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic strategies and Alzheimer's disease: contribution of animal models].
Chabrier PE
Ann Pharm Fr; 2009 Mar; 67(2):97-103. PubMed ID: 19298893
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease: transgenic models to test new chemicals and pharmaceuticals.
Miller CC; Anderton BH
Curr Opin Biotechnol; 1992 Dec; 3(6):683-6. PubMed ID: 1369125
[TBL] [Abstract][Full Text] [Related]
18. Zebrafish for Personalized Regenerative Medicine; A More Predictive Humanized Model of Endocrine Disease.
Arjmand B; Tayanloo-Beik A; Foroughi Heravani N; Alaei S; Payab M; Alavi-Moghadam S; Goodarzi P; Gholami M; Larijani B
Front Endocrinol (Lausanne); 2020; 11():396. PubMed ID: 32765420
[TBL] [Abstract][Full Text] [Related]
19. Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials.
Castrillo JI; Lista S; Hampel H; Ritchie CW
Methods Mol Biol; 2018; 1750():31-66. PubMed ID: 29512064
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
